Back to Search
Start Over
[Efficacy of uro-vaxom in recurrent infectious-inflammatory diseases of the urogenital system].
- Source :
-
Urologiia (Moscow, Russia : 1999) [Urologiia] 2011 Jul-Aug (4), pp. 7-11. - Publication Year :
- 2011
-
Abstract
- Our study prospects of urovaxom in improvement of efficacy and prevention of recurrent urogenital infection. One capsule of oral vaccine uro-vaxom was given daily for a month to 127 patients: 23 males with chronic bacterial prostatitis/urethroprostatitis, 75 females with chronic cystitis, 29 females with urolithiasis complicated with secondary chronic pyelonephritis. Control examination was made each two months for a year. In signs of inflammation the patients received one more course of uro-vaxom for a month. It was followed by control examinations each three month for a year. We observed a 6-12 month "cold" period after one course of uro-vaxom in 86.7% patients. After the second course of immunoprophylaxis recurrent urogenital infection occurred 8 times less often. Thus, immunoprophylaxis of urogenital infection with oral vaccine uro-vaxom is highly effective, is well tolerated and, therefore, must enter the standards of medical care for patients with urogenital infection.
- Subjects :
- Adjuvants, Immunologic administration & dosage
Adult
Escherichia coli immunology
Female
Humans
Male
Middle Aged
Prostatitis diagnosis
Prostatitis immunology
Secondary Prevention
Treatment Outcome
Urinary Tract Infections diagnosis
Urinary Tract Infections immunology
Young Adult
Adjuvants, Immunologic therapeutic use
Immunotherapy methods
Prostatitis prevention & control
Urinary Tract Infections prevention & control
Subjects
Details
- Language :
- Russian
- ISSN :
- 1728-2985
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Urologiia (Moscow, Russia : 1999)
- Publication Type :
- Academic Journal
- Accession number :
- 22066233